Osteogenics Biomedical introduces enCore™, the first particulate combination allograft
LUBBOCK, Texas – Osteogenics Biomedical, a leader in the development of innovative dental bone grafting products, introduces enCore™ Combination Allograft, the first particulate grafting product combining mineralized and demineralized bone in a single bottle.
By combining these two distinctly different allografts, the surgeon is able to employ the complementary benefits of space-maintaining mineralized bone with osteoinductive demineralized matrix to optimize the environment for the regeneration of vital bone.
“The concept of combining mineralized and demineralized bone for socket grafting and implant site development is already popular among many specialists,” said Osteogenics president Shane Shuttlesworth. “We’ve simply combined it in a single bottle from a single donor, tested it according to the gold standard in osteoinductivity, and utilized industry best-practices in safety.”
Each lot of enCore™ Combination Allograft undergoes a post-sterilization in vivo test for verification of osteoinductive potential. Additionally, each lot is bio-assayed for a threshold of BMP-2 to ensure product consistency.
During the processing of enCore™, best practices in tissue safety are utilized, such as single donor sourcing, rigorous donor screening and testing, terminal sterilization, and processing according to both FDA and AATB guidelines.
In addition to the combination allograft, enCore™ is also available as a mineralized-only allograft composed of 100 percent cortical bone. Both enCore™ Combination and Mineralized Allografts are available in a variety of sizes to treat a wide range of bony defects.
About Osteogenics Biomedical:
Headquartered in Lubbock, Texas, Osteogenics Biomedical is a leader in the development of innovative dental bone grafting products serving Periodontists, Oral & Maxillofacial Surgeons and clinicians involved in regenerative and implant dentistry throughout the world. Osteogenics offers a complete line of bone grafting products including enCore™ Combination and Mineralized Allografts, Cytoplast® barrier membranes, Cytoplast® PTFE suture, and the Pro-fix™ Precision Fixation System.